Stock NMRA NEUMORA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Neumora Therapeutics, Inc.

Equities

NMRA

US6409791000

Real-time Estimate Cboe BZX
Other stock markets
 03:18:40 2024-05-15 pm EDT 		5-day change 1st Jan Change
9.595 USD +0.16% Intraday chart for Neumora Therapeutics, Inc. +1.70% -43.81%
May. 14 Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression MT
May. 14 Neumora Therapeutics, Inc. Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
AQ
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
AQ
Neumora Therapeutics to Participate in Upcoming Conferences in May
AQ
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
AQ
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days
AQ
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AQ
Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer
AQ
Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
AQ
Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
AQ
Vanderbilt University: Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
AQ
Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study
AQ
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
AQ
Neumora Therapeutics to Participate in Upcoming Conferences in November
AQ
Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NMRA Stock
  4. News Neumora Therapeutics, Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW